Lexeo Therapeutics, Inc. Common Stock

LXEO · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$40,996$35,480$28,913$35,014
Short-Term Investments$0$97,413$70,918$86,504
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$86,797$7,169$5,443$4,603
Total Curr. Assets$127,793$140,062$105,274$126,121
Property Plant & Equip (Net)$9,413$9,755$10,133$10,557
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$23,003$7,035$7,012
Tax Assets$0$0$0$2,978
Other NC Assets$6,638$3,248$3,248$274
Total NC Assets$16,051$36,006$20,416$20,821
Other Assets$0$0$0$0
Total Assets$143,844$176,068$125,690$146,942
Liabilities
Payables$4,656$20,025$11,981$6,417
Short-Term Debt$2,715$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$9,900$2,397$1,702$4,657
Total Curr. Liab.$17,271$31,593$30,823$22,846
LT Debt$5,742$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$5,742$6,257$6,752$7,254
Other Liabilities$0$0$0$0
Cap. Leases$8,457$8,913$9,399$9,924
Total Liabilities$23,013$37,850$37,575$30,100
Equity
Pref Stock$0$0$0$0
Common Stock$5$5$3$3
Retained Earnings-$359,215-$338,932-$312,829-$280,173
AOCI$89-$13-$54-$103
Other Equity$479,952$0$0$0
Total Equity$120,831$138,218$88,115$116,842
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$143,844$176,068$125,690$146,942
Net Debt-$32,539-$35,480-$28,913-$35,014